-
Product Insights
Major Depressive Disorder – Drugs In Development, 2023
Global Markets Direct’s, ‘Major Depressive Disorder - Drugs In Development, 2023’, provides an overview of the Major Depressive Disorder pipeline landscape. The report provides comprehensive information on the therapeutics under development for Major Depressive Disorder, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Sector Analysis
Major Depressive Disorder in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2029
Major Depressive Disorder Market Report Overview The major depressive disorder (MDD) market sales across the 8 major markets (MM) were valued at $4.73 billion in 2019. The market is expected to achieve a CAGR of more than 7% during 2019-2029. The US market makes up the most total global sales due to the large MDD prevalent population, combined with the high price of medication in the country. Major Depressive Disorder Market Outlook, 2019-2029 ($ Billion) Buy the Full Report to...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.